Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:02 PM
Ignite Modification Date:
2025-12-24 @ 7:02 PM
NCT ID:
NCT03518957
Eligibility Criteria:
Inclusion Criteria:
* Female
* Age 21-70 years
* Histological or cytological diagnosis of breast carcinoma
* Stage I-III breast cancer
* Has undergone curative breast cancer surgery with no clinically measurable tumor
* Between 4-12 weeks from the last adjuvant radiotherapy or chemotherapy session, if given, whichever is later. Patients who do not receive adjuvant chemotherapy or radiotherapy can be enrolled and will be randomized within 4-12 weeks of breast cancer surgery.
* Able to sign informed consent
* Able to adhere to study procedures
Exclusion Criteria:
* Cardiovascular, respiratory, or musculoskeletal problems that preclude moderate physical activity
* Major medical problems deemed by the investigator to be unsuitable for enrollment
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
21 Years
Maximum Age:
70 Years
Study:
NCT03518957
Study Brief:
Protocol Section:
NCT03518957